Blog
RSS FeedPosted by Michael Wonder on 01 Sep 2020
Roche receives FDA approval for first HIV-1/HIV-2 Qualitative Test on the cobas 6800/8800 Systems in the fight against HIV/AIDS
1 September 2020 - Detects, confirms and differentiates HIV-1 and HIV-2 infections providing clinicians with critical diagnostic data for personalised management ...
Posted by Michael Wonder on 01 Sep 2020
Athenex announces FDA acceptance for filing of U.S. NDA for oral paclitaxel and encequidar in metastatic breast cancer with priority review
1 September 2020 - FDA grants priority review and sets PDUFA target action date of 28 February 2021. ...
Posted by Michael Wonder on 01 Sep 2020
Coronavirus vaccine before election unlikely — Dr. Gottlieb on FDA chief’s possible fast track
31 August 2020 - The former FDA commissioner said the more effective the vaccine is, and the more serious the U.S. ...
Posted by Michael Wonder on 01 Sep 2020
FDA approves first-of-its-kind automated insulin delivery and monitoring system for use in young paediatric patients
31 August 2020 - Today, the U.S. FDA approved the MiniMed 770G System, a hybrid closed loop diabetes management device that ...
Posted by Michael Wonder on 31 Aug 2020
Mezzion shares tumble on FDA’s return of heart disease med NDA
31 August 2020 - Mezzion has announced it has received a complete response letter from the U.S. FDA over its submitted ...
Posted by Michael Wonder on 31 Aug 2020
FDA approves Xaracoll (bupivacaine hydrochloride) implant, a non-opioid, drug-device treatment option for acute post-surgical pain relief for up to 24 hours following open inguinal hernia repair in adults
31 August 2020 - Xaracoll is a first-of-its-kind, fully bioresorbable collagen implant that delivers bupivacaine hydrochloride directly to the surgical site ...
Posted by Michael Wonder on 31 Aug 2020
FDA releases draft guidance on PROs for device manufacturers
31 August 2020 - Device manufacturers have new draft guidance from the US FDA for the selection of patient-reported outcome ...
Posted by Michael Wonder on 31 Aug 2020
VelosBio announces FDA fast track and orphan drug designations for VLS-101 in patients with mantle cell lymphoma
31 August 2020 - VelosBio today announced that the U.S. FDA has granted the company fast track and orphan drug designation ...
Posted by Michael Wonder on 31 Aug 2020
CorMedix announces FDA acceptance for filing and priority review of new drug application for Defencath
31 August 2020 - FDA sets PDUFA goal date of 28 February 2021. ...
Posted by Michael Wonder on 31 Aug 2020
A quick virus test? Sure, if you can afford it.
31 August 2020 - Standard tests in New York City can take days or weeks. Wealthier people are turning to concierge ...
Posted by Michael Wonder on 30 Aug 2020
FDA head says he is willing to fast-track COVID-19 vaccine
30 August 2020 - Stephen Hahn insists he will not rush process just to help Donald Trump’s election chances. ...
Posted by Michael Wonder on 30 Aug 2020
FDA grants priority review of melflufen for patients with triple-class refractory multiple myeloma
29 August 2020 - Oncopeptides today announces that the US FDA has granted priority review for Oncopeptides' new drug application ...
Posted by Michael Wonder on 29 Aug 2020
FDA ousts spokeswoman after COVID therapy misstatements
29 August 2020 - Emily Miller joined the agency as chief spokeswoman this month. ...
Posted by Michael Wonder on 29 Aug 2020
FDA announces Advisory Committee meeting to discuss COVID-19 vaccines
28 August 2020 - The U.S. Food and Drug Administration announced that a public meeting of the Vaccines and Related Biological ...
Posted by Michael Wonder on 29 Aug 2020
FDA broadens emergency use authorisation for Veklury (remdesivir) to include all hospitalised patients for treatment of COVID-19
28 August 2020 - Today, as part of its ongoing efforts to fight COVID-19, the U.S. FDA broadened the scope of ...